Medical Weight Loss for Wilmington, North Carolina Residents

Wilmington, North Carolina residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Wilmington through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Skip the commute, keep the care: from Downtown, the Riverwalk, and the greater Cape Fear coast and anywhere else in Wilmington, you meet your physician on a video call from home or work. We confirm telehealth eligibility during the consultation. Doctor review just $119 (medication separate).

Why Wilmington Residents Choose New Hope Weight Loss

If past attempts left you frustrated, Wilmington, the difference here is structure and honesty. There is a real physician, Dr. Anjmun Sharma, behind your plan, a transparent price you can see up front, and a program that meets you by telehealth instead of dragging you across North Carolina for every visit. Compounded semaglutide and tirzepatide are not magic and they are not FDA-approved, but paired with steady medical guidance they give a lot of people a genuine path forward.

Wilmington patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.

If you are searching for a weight-loss physician in Wilmington, the honest answer is that ours is in Costa Mesa, and thanks to telehealth that puts North Carolina patients exactly where local ones are. We care for patients throughout Downtown, the Riverwalk, and the greater Cape Fear coast. From your first question to your ongoing refills, the whole North Carolina experience is built to feel personal, private, and genuinely supported.

There are no local-office hours to fit your life around, so Wilmington patients can meet Dr. Sharma on evenings or between work without crossing town. If you would rather spread payments out, Wilmington patients can use Klarna or Affirm at checkout instead of paying the full cost at once. Across fast-growing North Carolina, New Hope Weight Loss provides physician-supervised GLP-1 care by telehealth from our Costa Mesa, California clinic, with no need to travel for a visit.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Wilmington patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Wilmington

From your first quiz to your last follow-up, the process is built for busy people in Wilmington.

1. Complete a secure online intake about your medical history and weight goals.

2. Dr. Sharma reviews it and meets you over secure video, usually within 48 hours.

3. If a compounded GLP-1 suits you, a state-licensed 503(a) pharmacy ships semaglutide or tirzepatide to your Wilmington home in cold-pack packaging.

4. You continue with video follow-ups, anywhere in , at the cadence your plan calls for.

Frequently Asked Questions, Wilmington

Is there a New Hope Weight Loss clinic near Wilmington?

Our physical clinic is in Costa Mesa, California, and we care for patients in Wilmington, North Carolina entirely by telehealth. You do not need a local office to start. Dr. Anjmun Sharma reviews your history and goals during a secure video consult, and your eligibility for a compounded GLP-1 program is confirmed there.

Do I have to travel to Costa Mesa from Wilmington for treatment?

No. Everything happens online, so Wilmington patients never drive to California. Your consult, follow-ups, and messaging run through a private portal. If you are approved, compounded semaglutide or tirzepatide ships straight to your Wilmington address in temperature-controlled cold-pack packaging to keep it stable in transit.

What does treatment cost for someone in Wilmington?

The physician review is $119. Compounded semaglutide starts at $166 a month, or $499 for the 90-day program, and tirzepatide starts at $233 a month. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, and there is no distance surcharge for Wilmington patients.

What areas of Wilmington do you serve?

We serve patients from across Wilmington by telehealth, including Downtown, the Riverwalk, and the greater Cape Fear coast.

What does treatment cost for Wilmington patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Wilmington.

Wilmington Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Wilmington, North Carolina by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.